Insider Transactions in Q1 2023 at Option Care Health, Inc. (OPCH)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2023
|
Harry M Jansen Kraemer Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,933
+3.99%
|
-
|
|
Mar 10
2023
|
Michael Bavaro Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
6,148
-22.2%
|
$190,588
$31.45 P/Share
|
|
Mar 10
2023
|
Michael Bavaro Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,605
+8.0%
|
$96,705
$21.46 P/Share
|
|
Mar 09
2023
|
Luke Whitworth Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,373
-1.78%
|
$42,563
$31.72 P/Share
|
|
Mar 09
2023
|
Richard Denness Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,522
-1.34%
|
$47,182
$31.72 P/Share
|
|
Mar 01
2023
|
Walgreens Boots Alliance, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
15,475,166
-58.96%
|
$464,254,980
$30.3 P/Share
|
|
Feb 23
2023
|
Michael Bavaro Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
434
-1.84%
|
$13,454
$31.9 P/Share
|
|
Feb 23
2023
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,679
-4.17%
|
$362,049
$31.9 P/Share
|
|
Feb 23
2023
|
Michael H. Shapiro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,421
-1.35%
|
$75,051
$31.9 P/Share
|
|
Feb 23
2023
|
Richard Denness Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,477
-1.29%
|
$45,787
$31.9 P/Share
|
|
Feb 22
2023
|
John Charles Rademacher Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
388,448
+26.22%
|
-
|
|
Feb 22
2023
|
Michael Bavaro Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,863
+26.42%
|
-
|
|
Feb 22
2023
|
Collin Smyser GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
15,811
+42.7%
|
-
|
|
Feb 22
2023
|
Luke Whitworth Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,670
+21.63%
|
-
|
|
Feb 22
2023
|
Michael H. Shapiro Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
158,555
+32.5%
|
-
|
|
Feb 22
2023
|
Richard Denness Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,776
+17.75%
|
-
|
|
Feb 21
2023
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,914
-6.66%
|
$137,592
$28.63 P/Share
|
|
Feb 21
2023
|
John Charles Rademacher Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,087
+13.06%
|
-
|
|
Feb 17
2023
|
Richard Denness Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
760
-1.12%
|
$22,040
$29.38 P/Share
|
|
Feb 17
2023
|
Richard Denness Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,348
+3.35%
|
-
|
|
Feb 17
2023
|
Michael H. Shapiro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,184
-5.39%
|
$34,336
$29.38 P/Share
|
|
Feb 17
2023
|
Michael H. Shapiro Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,652
+14.25%
|
-
|
|
Feb 17
2023
|
Michael Bavaro Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-3.82%
|
$11,136
$29.38 P/Share
|